Nasdaq:ALCO
ALICO, INC.
A legacy diversified holding company navigating a volatile transition phase between insurance stability and life sciences investment volatility.
Key Metrics
Investment Thesis
Bull Case
The company possesses a fortress-like liquidity position with nearly $39M in cash against manageable current liabilities, offering a safety net for distressed asset recovery. Positive investing cash flows of $24.1M indicate active balance sheet optimization or strategic divestitures that could unlock shareholder value. The diverse business model provides inherent hedging against sector-specific downturns if core insurance operations remain profitable.
Bear Case
The reported net loss of $147.5M and gross profit deficit of $192.2M signal severe underlying operational distress or massive impairment charges that erode book value. Revenue contraction in 2025 following two years of growth demonstrates a failing top-line trajectory that threatens long-term sustainability. The significant retained earnings deficit and high debt levels create a precarious capital structure vulnerable to interest rate hikes or credit tightening.
About ALICO, INC.
ALICO Inc. operates as a diversified holding company with interests in insurance, healthcare services, and life sciences across North America and Asia. The company leverages its deep-rooted heritage to provide comprehensive risk management solutions while investing in high-growth sectors like biotechnology. Recent financials reflect a complex restructuring period with significant non-cash adjustments impacting reported earnings.
Analysis
Management Discussion
Despite generating strong operating cash flow of $20.1M, the company recorded a massive net loss primarily due to non-cash adjustments exceeding $188M and negative gross profit figures. Management successfully deployed investing cash flows of $24.1M, likely from asset sales or investment liquidation, while refinancing revolver debt with net repayments of $5.9M. The divergence between positive operating cash flow and negative net income suggests earnings quality concerns warranting close scrutiny.
Industry Overview
The insurance and healthcare holding industry faces intense competition from digital-native disruptors and regulatory pressures on pricing models. Companies with diversified portfolios across insurance, wellness, and biotech are attempting to hedge against volatility in any single segment. Current market dynamics favor firms with low leverage and consistent underwriting profits, penalizing those with complex restructuring needs.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $39.8M | $46.6M | $44.1M |
| Cost of Revenue | $33.4M | $103.0M | $236.3M |
| Gross Profit | $6.4M | $-56.4M | $-192.2M |
| Operating Expenses | $10.6M | $11.1M | $11.7M |
| Operating Income | $-4.2M | $-67.5M | $-203.9M |
| G&A | $10.6M | $11.1M | $11.7M |
| Stock-Based Comp | $935.0K | $719.0K | $735.0K |
| D&A | $15.5M | $15.0M | $176.6M |
| Depreciation | — | $15.0M | $176.6M |
| Other OpEx | $0 | $0 | $0 |
| Non-Operating Income | $6.7M | $78.4M | $18.0M |
| Pre-Tax Income | $2.5M | $11.0M | $-185.9M |
| Income Tax | $801.0K | $4.6M | $-38.4M |
| Continuing Ops | $1.7M | $6.4M | $-147.5M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $1.7M | $6.4M | $-147.5M |
| Minority Interest | $-177.0K | $-618.0K | $-174.0K |
| Net to Common | $1.8M | $7.0M | $-147.3M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $58.8M | $40.6M | $54.9M |
| Cash & Equivalents | $1.1M | $3.1M | $38.1M |
| Accounts Receivable | $712.0K | $771.0K | $1.0M |
| Inventory | $52.5M | $30.1M | $4.2M |
| Prepaid Expenses | $1.7M | $1.6M | $2.0M |
| Other Current Assets | $2.8M | $5.1M | $9.5M |
| Long-Term Assets | $369.5M | $358.1M | $146.6M |
| PP&E (Net) | $361.8M | $352.7M | $142.1M |
| Goodwill | $2.2M | $2.2M | $2.2M |
| Operating Leases | $523.0K | $293.0K | $154.0K |
| Other LT Assets | $4.9M | $2.8M | $2.1M |
| Total Assets | $428.4M | $398.7M | $201.5M |
| Current Liabilities | $15.1M | $10.7M | $5.7M |
| Accounts Payable | $6.3M | $3.4M | $403.0K |
| Current Debt | $2.6M | $1.4M | $250.0K |
| Current Leases | $254.0K | $153.0K | $150.0K |
| Other Current Liab | $190.0K | $-21.0K | $-5.0K |
| Long-Term Liabilities | $162.9M | $131.8M | $87.8M |
| Long-Term Debt | $101.4M | $82.3M | $82.8M |
| LT Operating Leases | $305.0K | $170.0K | $14.0K |
| Other LT Liab | $61.2M | $49.3M | $5.0M |
| Total Liabilities | $178.0M | $142.4M | $93.5M |
| Shareholders' Equity | $250.4M | $256.3M | $108.0M |
| Retained Earnings | $243.8M | $249.3M | $100.4M |
| Treasury Stock | — | — | $26.2M |
| Total L&E | $428.4M | $398.7M | $201.5M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $1.7M | $6.4M | $-147.5M |
| Non-Cash Adjustments | $-36.5M | $-60.3M | $188.0M |
| Working Capital Changes | $28.6M | $23.4M | $-20.4M |
| Cash from Operations | $-6.3M | $-30.5M | $20.1M |
| Capital Expenditures | $16.7M | $17.9M | $5.5M |
| Cash from Investing | $-4.1M | $68.2M | $24.1M |
| Dividends Paid | $4.9M | $1.5M | $1.5M |
| Cash from Financing | $13.2M | $-38.0M | $-8.8M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $2.8M | $-294.0K | $35.5M |
| Beginning Cash | $865.0K | $3.7M | $3.4M |
| Ending Cash | $3.7M | $3.4M | $38.9M |
Frequently Asked Questions
How does ALICO, INC. make money?
The company derives revenue from traditional insurance operations, healthcare service providers, and strategic equity investments in life sciences. Financial data indicates heavy reliance on non-operating income and significant capital expenditures to support these diverse verticals, alongside substantial depreciation charges typical of asset-heavy insurance subsidiaries.
What are the main risks for ALCO?
Severe reported net loss of $147.5M driven by large non-cash adjustments and negative gross profit, obscuring underlying operational cash flow. High leverage with long-term debt of $82.8M and current portion due soon. Volatile revenue trend showing contraction in 2025 compared to prior year growth. Significant retained earnings deficit of over $100M limiting future dividend sustainability.
What is ALCO's competitive advantage?
Strong balance sheet with over $38M in cash and equivalents providing liquidity for strategic M&A or debt repayment. Deep institutional knowledge and global footprint allowing cross-border risk diversification. Established brand reputation in the Japanese-American market offering trust-based customer relationships.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.